Active surveillance (AS) has evolved as a strategy alternative to radical treatments for very low risk and low-risk prostate cancer (PCa). However, current criteria for selecting AS patients are still suboptimal. Here, we performed an unprecedented analysis of the circulating miRNome to investigate whether specific miRNAs associated with disease reclassification can provide risk refinement to standard clinicopathological features for improving patient selection. The global miRNA expression profiles were assessed in plasma samples prospectively collected at baseline from 386 patients on AS included in three independent mono-institutional cohorts (training, testing and validation sets). A three-miRNA signature (miR-511-5p, miR-598-3p and miR-199a-5p) was found to predict reclassification in all patient cohorts (training set: AUC 0.74, 95% CI 0.60–0.87, testing set: AUC 0.65, 95% CI 0.51–0.80, validation set: AUC 0.68, 95% CI 0.56–0.80). Importantly, the addition of the three-miRNA signature improved the performance of the clinical model including clinicopathological variables only (AUC 0.70, 95% CI 0.61–0.78 vs. 0.76, 95% CI 0.68–0.84). Overall, we trained, tested and validated a three-miRNA signature which, combined with selected clinicopathological variables, may represent a promising biomarker to improve on currently available clinicopathological risk stratification tools for a better selection of truly indolent PCa patients suitable for AS.
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables / P. Gandellini, C.M. Ciniselli, T. Rancati, C. Marenghi, V. Doldi, R. El Bezawy, M. Lecchi, M. Claps, M. Catanzaro, B. Avuzzi, E. Campi, M. Colecchia, F. Badenchini, P. Verderio, R. Valdagni, N. Zaffaroni. - In: CANCERS. - ISSN 2072-6694. - 13:10(2021 May).
|Titolo:||Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables|
VALDAGNI, RICCARDO (Penultimo)
|Parole Chiave:||Active surveillance; Biomarker; MicroRNA; Prostate cancer|
|Settore Scientifico Disciplinare:||Settore MED/04 - Patologia Generale|
|Data di pubblicazione:||mag-2021|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3390/cancers13102433|
|Appare nelle tipologie:||01 - Articolo su periodico|